Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment
- Status
- TERMINATED
- Phase
- PHASE2
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
- Status
- COMPLETED
- Phase
- PHASE2
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
- Status
- COMPLETED
- Phase
- PHASE2
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
- Status
- COMPLETED
- Phase
- PHASE2
Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)
- Status
- COMPLETED
- Phase
- PHASE3
Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)
- Status
- COMPLETED
- Phase
- PHASE3
Osteoarthritis Initiative (OAI): A Knee Health Study
- Status
- COMPLETED
- Phase
- N/A
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
- Status
- TERMINATED
- Phase
- PHASE2
Angiotensin II Blockade for Chronic Allograft Nephropathy
- Status
- COMPLETED
- Phase
- PHASE4
Minimally Invasive Surgical Therapy for BPH
- Status
- TERMINATED
- Phase
- PHASE3
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)
- Status
- COMPLETED
- Phase
- PHASE3
Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE3